← Back to Analyst Consensus 
XENE Buy
Xenon Pharmaceuticals Inc.
Current Price —
Implied Upside —
Analysts 26
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (15 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 18, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Sep 18, 2026 | Wedbush | maintain | Outperform → Outperform | — | 57% |
| Sep 18, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Sep 18, 2026 | Deutsche Bank | downgrade | Buy → Hold | — | 57% |
| Sep 18, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Sep 18, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Aug 7, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| May 27, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| May 12, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| May 8, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| May 8, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Mar 16, 2026 | Wedbush | maintain | Outperform → Outperform | — | 57% |
| Mar 10, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Mar 10, 2026 | Wedbush | maintain | Outperform → Outperform | — | 57% |
| Mar 10, 2026 | Deutsche Bank | maintain | Buy → Buy | — | 57% |
| Mar 10, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 9, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Mar 9, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Feb 27, 2026 | Needham | maintain | Buy → Buy | $58 | 50% |
| Feb 27, 2026 | Wells Fargo | maintain | Overweight → Overweight | $49 | 54% |
| Feb 24, 2026 | Wolfe Research | initiate | — → Outperform | $60 | 54% |
| Jan 9, 2026 | JP Morgan | maintain | Overweight → Overweight | $62 | 55% |
| Dec 11, 2025 | Wells Fargo | maintain | Overweight → Overweight | $48 | 54% |
| Nov 18, 2025 | JP Morgan | maintain | Overweight → Overweight | $60 | 55% |
| Nov 4, 2025 | RBC Capital | maintain | Outperform → Outperform | $58 | 55% |
| Nov 4, 2025 | Wells Fargo | maintain | Overweight → Overweight | $44 | 54% |
| Nov 4, 2025 | Needham | reiterate | Buy → Buy | $55 | 50% |
| Oct 7, 2025 | Chardan Capital | maintain | Buy → Buy | $55 | 46% |
| Sep 2, 2025 | RBC Capital | reiterate | Outperform → Outperform | $55 | 55% |
| Aug 12, 2025 | Chardan Capital | maintain | Buy → Buy | $55 | 46% |
| Aug 12, 2025 | RBC Capital | maintain | Outperform → Outperform | $55 | 55% |
| Aug 12, 2025 | Wedbush | maintain | Outperform → Outperform | $43 | 57% |
| Jun 13, 2025 | RBC Capital | maintain | Outperform → Outperform | $57 | 55% |
| May 14, 2025 | Evercore ISI Group | initiate | — → Outperform | $55 | 58% |
| May 13, 2025 | Wells Fargo | maintain | Overweight → Overweight | $47 | 54% |
| May 13, 2025 | RBC Capital | maintain | Outperform → Outperform | $55 | 55% |
| May 13, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $53 | 44% |
| May 13, 2025 | Needham | maintain | Buy → Buy | $55 | 50% |
| May 13, 2025 | Chardan Capital | maintain | Buy → Buy | $55 | 46% |
| May 7, 2025 | Chardan Capital | initiate | — → Buy | $55 | 46% |
| Apr 17, 2025 | Goldman Sachs | maintain | Buy → Buy | $52 | 54% |
| Feb 24, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $53 | 44% |
| Feb 11, 2025 | Deutsche Bank | initiate | — → Buy | $67 | 57% |
| Dec 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $53 | 44% |
| Nov 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $53 | 44% |
| Nov 13, 2024 | Needham | reiterate | Buy → Buy | $60 | 50% |
| Oct 1, 2024 | HC Wainwright & Co. | initiate | — → Buy | $53 | 44% |
| Sep 3, 2024 | RBC Capital | reiterate | Outperform → Outperform | $55 | 55% |
| Aug 12, 2024 | Needham | maintain | Buy → Buy | $60 | 50% |
| Aug 9, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $65 | 50% |
Price Target Trend
Jun 2, 2026 Latest: $71.94 Oct 24, 2026
EPS Estimates
0q $-1.15
Lo: $-1.29 Hi: $-0.94
13 analysts ▲1
+1y $-4.72
Lo: $-5.50 Hi: $-1.90
14 analysts ▲1
0y $-4.63
Lo: $-4.93 Hi: $-4.06
14 analysts ▲1
+1q $-1.17
Lo: $-1.35 Hi: $-0.85
13 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days